Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Roche’s Brainshuttle technology promises next generation of amyloid beta mAbs, says GlobalData

At the recently held AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, Roche presented interim trial data for its novel anti-amyloid monoclonal antibody (mAb), trontinemab, to clinically validate its proprietary Brainshuttle technology for the treatment of prodromal or mild to moderate Alzheimer’s disease (AD). The presentation showcased promising results from early clinical experience, with […]
Read more

APAC automotive semi-active suspension systems market to record 16% CAGR over 2024-29, forecasts GlobalData

The automotive landscape in the Asia-Pacific (APAC) region is undergoing a transformative shift, driven by the increasing demand for advanced suspension technologies. With their ability to enhance ride comfort and handling stability while maintaining energy efficiency, semi-active suspensions are poised to redefine vehicle dynamics across a diverse range of automotive applications. Against this backdrop, the […]
Read more

Great Depression trends on social media amid rising US tariff fears, reveals GlobalData

The concept of the “Great Depression” has gained traction among the social media influencers in first week of April 2025, largely driven by discussions surrounding the US tariff turmoil and concerns about potential economic downturns. The surge in discussion is closely tied to comparisons being drawn between the current economic policies, particularly tariffs, and those […]
Read more

US home insurance premiums set to climb as Trump tariffs drive up construction material costs, reveals GlobalData

The US homeowners are grappling with soaring insurance premiums, now the highest among surveyed nations, as rising rebuild costs compound financial pressure. The recent tariffs on imported construction materials—especially from China—threaten to further inflate costs, prompting insurers to reassess pricing strategies. With affordability and coverage adequacy at risk, the industry faces a critical juncture demanding […]
Read more

F-16 fighter jet deal bolsters Philippines air defense amid rising regional tensions, says GlobalData

In a significant step toward strengthening the air defense capabilities of the Philippines, the US government has approved the potential sale of 20 F-16 fighter jets valued at approximately $5.6 billion. This acquisition will enhance the Philippine Air Force’s ability to safeguard its airspace, improve regional security, and boost interoperability with allied forces in the […]
Read more

APAC automotive connected vehicle technology market to record 0.6% CAGR over 2024-29, forecasts GlobalData

The Asia-Pacific (APAC) region stands at the forefront of the connected vehicle technology revolution. With a burgeoning population of tech-savvy consumers and a rapidly expanding automotive market, the integration of connectivity features into vehicles is not just a trend but a transformative shift that promises to redefine mobility in the region. Against this backdrop, the […]
Read more

Job cuts at US health agencies raise concerns over drug approvals and supply chain stability, reveals GlobalData

The widespread job cuts and regulatory shifts at key US health agencies, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), are fueling concerns over potential delays in drug and medical device approvals. These developments could destabilize the pharmaceutical supply chain and drive companies to prioritize markets outside […]
Read more

Prasinezumab hints PD progression delay as assessed by time-to-event, says GlobalData

At the recently held AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (PD), Roche announced topline results of prasinezumab in patients with early Parkinson’s disease (PD) on stable symptomatic treatment (PADOVA [NCT04777331]). The presentation highlighted the potential of prasinezumab at delaying PD motor progression as assessed with time-to-event endpoints, says GlobalData, a leading data […]
Read more

Malaysia credit and charge card payments market to grow by 6.8% in 2025, forecasts GlobalData

Malaysia’s credit and charge card payments market is expected to register a growth of 6.8% to reach MYR245.7 billion ($53.7 billion) in 2025. This growth will be driven by the rising consumer spending and increasing consumer preference for cashless transactions, reveals GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that credit […]
Read more

Asian equities lead global sell-off after US-China trade dispute escalates, says GlobalData

Following the announcement of President Donald Trump’s sweeping tariffs across the world coupled with China’s retaliatory measures; Murthy Grandhi, Company Profiles Analyst at GlobalData, a leading data and analytics company, offers his view: “Global financial markets were rocked on Monday (07 April 2025) by a widespread sell-off, as escalating recession fears and a sudden tariff […]
Read more

China braces for tariff shock with strategic policy measures, says GlobalData

Following President Donald Trump’s announcement of sweeping unprecedented tariffs on Chinese imports; Arnab Nath, Associate Project Manager, Business Fundamentals at GlobalData, a leading data and analytics company, offers his view: “In a move set to redefine global trade dynamics, the US President Donald Trump has announced a sweeping 34% hike in tariffs on Chinese imports—bringing […]
Read more

Australia card payments market to grow at 6.3% in 2025, forecasts GlobalData

The Australian card payments market is projected to reach AUD1.1 trillion ($726.4 billion) in 2025e, growing at 6.3% compared to the previous year. This growth is driven by the rising consumer spending and increasing consumer preference for cashless transactions, reveals GlobalData, a leading data and analytics company. GlobalData’s report, “Australia Cards and Payments: Opportunities and […]
Read more

Alzheon’s valiltramiprosate poised to meet high unmet need for MCI APOE4 homozygotes, says GlobalData

At the recently held AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases (PD), Alzheon presented promising Phase III APOLLOE4 trial results for its drug ALZ-801 (valiltramiprosate) in treating mild cognitive impairment (MCI) in APOE4 homozygous patients, highlighting its potential to meet the high unmet need for a safe, effective treatment in this population, says […]
Read more
1 … 31 32 33 34 35 … 206